OR <-> RR Conversion & Effect Size Transformations
Source:vignettes/or-rr-effect-sizes.Rmd
or-rr-effect-sizes.RmdOverview
Network Meta-Analysis (NMA) requires all treatment effects on a common scale. However, trials report results as Odds Ratios, Relative Risks, or Standardised Mean Differences depending on the outcome type. ParCC provides bidirectional conversions to unify these metrics before pooling.
Tutorial: Preparing Data for an NMA in Depression
The Scenario
You are conducting an NMA comparing three antidepressants. Your systematic review found:
- Trial A (Drug vs Placebo): OR = 1.85 for “Response” (>=50% reduction in HAM-D). Baseline response in placebo arm = 30%.
- Trial B (Drug vs Placebo): RR = 1.42 for “Response”.
- Trial C (Drug vs Placebo): Reports a continuous outcome: SMD = 0.45 (Cohen’s d) on HAM-D score.
To pool these in a single NMA, you need all three on the same scale.
Step 1: Convert OR to RR (Zhang & Yu Method)
The Zhang & Yu (1998) formula accounts for baseline risk:
where is the baseline risk in the control group.
In ParCC:
- Navigate to Convert > Rate <-> Probability > OR <-> RR tab.
- Select direction: OR -> RR.
- Input OR = 1.85, Baseline Risk = 0.30.
- Result: RR ~ 1.42.
Why This Matters
If the outcome were rare (<10%), OR ~ RR and conversion wouldn’t matter. But with a 30% baseline risk, the OR of 1.85 overstates the effect compared to the RR of 1.42. Failing to convert would bias the NMA.
When to Use These Conversions
| Scenario | Conversion | Method |
|---|---|---|
| NMA mixing binary effect measures | OR -> RR or RR -> OR | Zhang & Yu (1998) |
| NMA mixing binary + continuous outcomes | SMD -> log(OR) | Chinn (2000) |
| Clinical interpretation of OR | OR -> RR | Zhang & Yu – RR is more intuitive |
| Checking the rare-disease approximation | Compare OR and RR at your baseline risk | If they diverge >10%, convert explicitly |
The Rare-Disease Approximation
When the baseline risk is very low (), OR ~ RR mathematically. ParCC displays a note when this approximation holds. For common outcomes (>10%), always convert explicitly.
References
- Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690-1691.
- Chinn S. A simple method for converting an odds ratio to effect size for use in meta-analysis. Statistics in Medicine. 2000;19(22):3127-3131.
- Cochrane Handbook for Systematic Reviews of Interventions, Chapter 12: Synthesizing and presenting findings using other methods.